MedDataX Logo

Investigation on the Hesitancy of COVID-19 Vaccination Among Liver Transplant Recipients in China

NCT05532592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 449

Last updated 2022-09-08

No results posted yet for this study

Summary

On WeChat platform, through a point-to-point connection, and carry on the questionnaire survey to collect information of liver transplant recipients followed-up by the department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Patients meeting inclusion and exclusion criteria will be selected. Conduct statistical analysis to describe the incidence of adverse reactions related to COVID-19 vaccine after liver transplantation, and to compare and evaluate the factors leading to COVID-19 vaccine hesitancy.

Conditions

  • Vaccine Hesitancy

Interventions

OTHER

Perceptions and attitudes towards COVID-19 and COVID-19 vaccine

Attitude towards COVID-19; Knowledge about COVID-19 vaccine

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Yongbing Qian, Prof · The department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-27
Primary Completion
2022-05-10
Completion
2022-05-30

Countries

  • China

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05532592 on ClinicalTrials.gov